Healthcare Device Company Valuation
Value a medical device company using revenue multiples, regulatory clearance premium, and pipeline analysis. Reports.
29 valuation methods · 43 industries · Results in under 10 minutes
Who this is for
Medical device founders seeking strategic acquisition or growth equity, large medtech corporate development teams benchmarking bolt-on targets, and medtech venture investors marking positions to market.
Valuation methods we use
Commercial-stage medical device companies are valued on revenue multiples (3–8×) and EBITDA multiples (15–25× for high-growth devices). Pre-commercial devices are valued on pipeline-adjusted comparable transaction analysis. This tool is informational only. Output is driven by your inputs and does not constitute a formal appraisal or certified valuation.
What drives value in Healthcare Devices
- FDA clearance or approval status (510(k), PMA, De Novo) and IP protection
- Recurring revenue from disposables, service contracts, or software subscriptions
- Clinical evidence depth and published outcomes data
- Commercial traction: procedure volumes, installed base, and ASP trends
- Sales force infrastructure and GPO/IDN contract coverage
- Pipeline of next-generation products leveraging cleared platform
Value your business in under 10 minutes
- 1.Upload your financial statements, or type the figures in.
- 2.Confirm the add-backs and the industry details the model asks for.
- 3.Get a valuation range, the methods behind it and a PDF memorandum.
Typical metrics and inputs
Recurring revenue %
Share of revenue from disposables, service, or SaaS; recurring revenue commands higher multiples than capital equipment.
ASP trend
Average selling price trajectory; rising ASP signals commercial execution and value capture.
Procedure volume growth
Year-over-year growth in procedures using the device; the leading commercial adoption indicator.
Gross margin
Typically 55–75% for medical devices; higher for software-embedded or disposable-heavy models.
Revenue growth rate
Annual revenue growth; 20–50%+ YoY is expected for premium multiples in medtech.
Example scenarios
FDA-cleared minimally invasive surgical device
A surgical device company with $10 M revenue growing 40%, 65% gross margin, and expanding procedure adoption might be valued at 5–7× revenue by a strategic acquirer.
Software-embedded diagnostic device
A diagnostic device with embedded AI software, $3 M ARR from SaaS subscriptions, and 510(k) clearance might trade at 8–12× revenue.
Further reading
How to Value a Dental Practice: Collections, EBITDA, and What DSOs Actually Pay
Dental practice valuation explained: the percentage-of-collections rule, when EBITDA multiples take over, what drives DSO offers, and a worked example for a $900K practice.
Is a Business Worth 3 Times Profit? When It Is 2x, When It Is 5x, and Which Profit Counts
Is a business worth 3 times profit? Often, if the profit is SDE. When 2x or 5x applies instead, which profit counts, and what diligence does to the price.
How Much Is a Business Worth With $500,000 in Sales? The Revenue Ladder From $100K to $3 Million
Revenue does not set a price, earnings do. See what businesses at $100K, $200K, $300K, $500K, $1M, $2M and $3M in sales are worth at 10%, 20% and 30% margins.
Frequently asked questions
What multiple does a medical device company sell for?
Commercial-stage devices with strong growth: 4–8× revenue. Profitable medtech platforms: 15–25× EBITDA. Strategic premiums can push these higher for category-defining products.
How much does FDA clearance add to value?
Significant - FDA clearance de-risks the clinical and regulatory path, unlocking commercial adoption. A cleared device is typically valued at 5–10× the value of a pre-cleared device in the same category.
Why does recurring revenue matter for medical devices?
Disposable or software-linked revenue extends customer LTV, reduces revenue volatility, and supports SaaS-like valuation multiples rather than one-time capital equipment multiples.
What do large medtech companies look for in acquisitions?
Technology platform adjacency, strong clinical evidence, GPO/IDN access, and a commercial team that can accelerate with the acquirer's distribution network.
Is this a certified appraisal?
No. This tool provides informational estimates. For formal medtech M&A, engage a healthcare-focused investment banker.
As featured in
Run your Healthcare Devices valuation
Get a valuation range with the methods behind it and a PDF memorandum in under 10 minutes.
Related industries
Biotech & Pharma
Value a biotech or pharmaceutical company using rNPV, pipeline analysis, and pharma comparable transactions.
Medical Labs
Value a clinical or diagnostic lab on its test volume and the net reimbursement it collects per test, with fee-schedule pressure and operating leverage read as buyers do.
Clinic Rollup / DSO
Value a clinic group or dental service organization on normalized EBITDA, with the multiple set by payer mix and acquired and new clinics as layers.
Healthcare Services
Value a healthcare services company on normalized EBITDA, with the multiple chosen from the payer mix: commercial insurers pay more than government plans.